|
US2021045967A1
|
|
System and method for optimization of cpr chest compressions
|
|
WO2021030423A1
|
|
Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and other pathologies
|
|
US2020397590A1
|
|
Constrained acetabular liner
|
|
WO2020227603A1
|
|
Hmgb1 antagonist
|
|
WO2020227588A1
|
|
Peptidomimetic agents, synthesis and uses thereof
|
|
US2020354318A1
|
|
Thiosemicarbazates and uses thereof
|
|
WO2020227594A1
|
|
Compounds for use in synthesis of peptidomimetics
|
|
WO2020227194A1
|
|
Interferon regulatory factor 5 inhibitors and uses thereof
|
|
US2020319190A1
|
|
Lipidomics-based identification of patients for treatment of cancer using computed normalized ratios of circulating phospholipids
|
|
WO2020123611A1
|
|
Choline acetyltransferase as a therapy for hypertension
|
|
WO2020112613A1
|
|
Hepatic ultrasound improves metabolic syndrome, fatty liver disease and insulin resistance and decreases body weight
|
|
US2020094055A1
|
|
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
|
|
WO2020068719A1
|
|
Combined sirolimus and nintedanib therapy for vascular lesions and hereditary hemorrhagic telangiectasia
|
|
AU2019232760A1
|
|
Methods for detecting and treating endometriosis
|
|
US2019247659A1
|
|
Treatment of inflammation by selective DMV cholinergic neuron stimulation
|
|
AU2018309700A1
|
|
Auricular stimulation device
|
|
US2020179600A1
|
|
Systems and methods for real-time monitoring of physiological biomarkers through nerve signals and uses thereof
|
|
US2018021217A1
|
|
Treatment of bleeding by non-invasive stimulation
|
|
US2020170638A1
|
|
Hernia repair device
|
|
AU2016219951A1
|
|
Nerve stimulation for treatment of diseases and disorders
|
